Árpád Szántó

531 total citations
35 papers, 391 citations indexed

About

Árpád Szántó is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Árpád Szántó has authored 35 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Árpád Szántó's work include Renal cell carcinoma treatment (7 papers), Renal and related cancers (7 papers) and Pediatric Urology and Nephrology Studies (4 papers). Árpád Szántó is often cited by papers focused on Renal cell carcinoma treatment (7 papers), Renal and related cancers (7 papers) and Pediatric Urology and Nephrology Studies (4 papers). Árpád Szántó collaborates with scholars based in Hungary, Germany and United Arab Emirates. Árpád Szántó's co-authors include Zita Bognár, Ferenc Gallyas, Gyula Kovács, László Márk, Alíz Szabó, Balázs Sümegi, Gábor Várbiró, László Farkas, Á. Török and Zsuzsanna Tucsek and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and International Journal of Molecular Sciences.

In The Last Decade

Árpád Szántó

32 papers receiving 389 citations

Peers

Árpád Szántó
Árpád Szántó
Citations per year, relative to Árpád Szántó Árpád Szántó (= 1×) peers Yunbei Xiao

Countries citing papers authored by Árpád Szántó

Since Specialization
Citations

This map shows the geographic impact of Árpád Szántó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Árpád Szántó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Árpád Szántó more than expected).

Fields of papers citing papers by Árpád Szántó

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Árpád Szántó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Árpád Szántó. The network helps show where Árpád Szántó may publish in the future.

Co-authorship network of co-authors of Árpád Szántó

This figure shows the co-authorship network connecting the top 25 collaborators of Árpád Szántó. A scholar is included among the top collaborators of Árpád Szántó based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Árpád Szántó. Árpád Szántó is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Szántó, Árpád, et al.. (2024). MALDI Imaging Mass Spectrometry Reveals Lipid Alterations in Physiological and Sertoli Cell-Only Syndrome Human Testicular Tissue Sections. International Journal of Molecular Sciences. 25(15). 8358–8358. 1 indexed citations
2.
Márk, László, et al.. (2024). An Alternative Application of Magnetic-Activated Cell Sorting: CD45 and CD235a Based Purification of Semen and Testicular Tissue Samples. International Journal of Molecular Sciences. 25(7). 3627–3627. 2 indexed citations
3.
Szántó, Árpád, et al.. (2024). Meddőségi kezelésben részt vevő nők és férfiak életviteli szokásainak felmérése. Orvosi Hetilap. 165(36). 1423–1432.
4.
Márk, László, et al.. (2023). Oxido-Reduction Potential as a Method to Determine Oxidative Stress in Semen Samples. International Journal of Molecular Sciences. 24(15). 11981–11981. 5 indexed citations
5.
Márk, László, et al.. (2023). Estrogenic and Non-Estrogenic Disruptor Effect of Zearalenone on Male Reproduction: A Review. International Journal of Molecular Sciences. 24(2). 1578–1578. 48 indexed citations
6.
Szántó, Árpád, et al.. (2022). Application of Mass Spectrometry Imaging in Uro-Oncology: Discovering Potential Biomarkers. Life. 12(3). 366–366. 3 indexed citations
7.
Stojanović, Borko, et al.. (2021). Metoidioplasty: Surgical Options and Outcomes in 813 Cases. Frontiers in Endocrinology. 12. 760284–760284. 18 indexed citations
8.
Flaskó, Tibor, et al.. (2020). Impaired Vitamin D Signaling Is Associated With Frequent Development of Renal Cell Tumor in End-stage Kidney Disease. Anticancer Research. 40(11). 6525–6530. 3 indexed citations
9.
Yusenko, Maria V, et al.. (2019). M2 Macrophage Marker Chitinase 3-Like 2 (CHI3L2) Associates With Progression of Conventional Renal Cell Carcinoma. Anticancer Research. 39(12). 6939–6943. 14 indexed citations
10.
Yusenko, Maria V, et al.. (2019). Dual role of KRT17: development of papillary renal cell tumor and progression of conventional renal cell carcinoma. Journal of Cancer. 10(21). 5124–5129. 13 indexed citations
11.
Szántó, Árpád, et al.. (2018). Shift of Keratin Expression Profile in End-stage Kidney Increases the Risk of Tumor Development. Anticancer Research. 38(9). 5217–5222. 9 indexed citations
12.
Bognár, Zita, Katalin Fekete, Csenge Antus, et al.. (2017). Desethylamiodarone—A metabolite of amiodarone—Induces apoptosis on T24 human bladder cancer cells via multiple pathways. PLoS ONE. 12(12). e0189470–e0189470. 18 indexed citations
13.
Farkas, Nelli, et al.. (2016). Lack of TMEM27 expression is associated with postoperative progression of clinically localized conventional renal cell carcinoma. Journal of Cancer Research and Clinical Oncology. 142(9). 1947–1953. 6 indexed citations
14.
Bagheri, Fariborz, László Farkas, Panagiotis Kallidonis, et al.. (2016). Impact of parenchymal loss on renal function after laparoscopic partial nephrectomy under warm ischemia. World Journal of Urology. 34(12). 1629–1634. 7 indexed citations
15.
Kvell, Krisztián, Gergely Talabér, Péter Ács, et al.. (2015). Thymic Atrophy and Apoptosis of CD4+CD8+ Thymocytes in the Cuprizone Model of Multiple Sclerosis. PLoS ONE. 10(6). e0129217–e0129217. 28 indexed citations
16.
Péntek, Márta, László Gulàcsi, Petra Baji, et al.. (2014). Health Related Quality of Life in Patients with Bladder Cancer: A Cross-Sectional Survey and Validation Study of the Hungarian Version of the Bladder Cancer Index. Pathology & Oncology Research. 21(3). 619–627. 17 indexed citations
17.
Szántó, Árpád, Zita Bognár, Zsuzsanna Tucsek, et al.. (2009). PARP-1 inhibition-induced activation of PI-3-kinase-Akt pathway promotes resistance to taxol. Biochemical Pharmacology. 77(8). 1348–1357. 44 indexed citations
18.
Bognár, Zita, Tamás Kálai, Anita Pálfi, et al.. (2006). A novel SOD-mimetic permeability transition inhibitor agent protects ischemic heart by inhibiting both apoptotic and necrotic cell death. Free Radical Biology and Medicine. 41(5). 835–848. 35 indexed citations
19.
Székely, J., et al.. (2006). UP-01.14. Urology. 68. 227–227. 1 indexed citations
20.
Somogyi, László, et al.. (1992). Long-term BCG immune therapy of superficial bladder tumours. International Urology and Nephrology. 24(2). 131–137.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026